AbbVie
ABBV
₹15,577
Share price
2.37%
Change (1 day)
10.17%
Change (1 year)
Categories
The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol “ABBV”.
Earnings for AbbVie (ABBV)
Earnings in 2024 (TTM): ₹305.05 Billion
According to AbbVie's latest financial reports the company's current earnings are ₹56.33 Billion. a decrease over its 2023 earnings that were of ₹541.34 Billion. The earnings displayed on this page is the company's Pretax Income.
Earnings history for AbbVie from 2011 to 2024
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2024  | ₹321.86 B | -40.54% |
| 2023 | ₹541.34 B | -53.62% |
| 2022 | ₹1.167 T | 3.76% |
| 2021 | ₹1.125 T | 282.25% |
| 2020 | ₹294.32 B | -59.67% |
| 2019 | ₹729.82 B | 62.13% |
| 2018 | ₹450.14 B | -32.74% |
| 2017 | ₹669.28 B | -1.99% |
| 2016 | ₹682.88 B | 18.65% |
| 2015 | ₹575.56 B | 180.5% |
| 2014 | ₹205.19 B | -55.57% |
| 2013 | ₹461.83 B | -6.86% |
| 2012 | ₹495.86 B | 56.05% |
| 2011 | ₹317.75 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 | ₹962.56 B | 199.06% | 🇺🇸 USA |
 | -₹725.76 Billion | -325.48% | 🇺🇸 USA |
 | ₹1.098 T | 241.24% | 🇺🇸 USA |
 | ₹399.21 B | 24.03% | 🇺🇸 USA |
 | ₹59.76 B | -81.43% | 🇺🇸 USA |
 | ₹165.09 B | -48.71% | 🇺🇸 USA |
 | ₹380.63 B | 18.26% | 🇬🇧 UK |
 | ₹903.66 B | 180.76% | 🇬🇧 UK |
 | ₹44.45 B | -86.19% | 🇺🇸 USA |